Skip to main content
Log in

A case of inclusion body myositis responsive to prednisolone therapy

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Inclusion body myositis, although rare, is the commonest cause of myopathy in patients aged over 50 years. The suggested pathogenesis remains uncertain and its prognosis remains poor. There have been select case reports of its association with an inflammatory etiology and it is postulated that this group of patients respond better to immunosuppressive therapy. We therefore report a rare case of inclusion body myositis that responded well to immunosuppressive therapy. We also report the possibility of its association with infliximab therapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 325:1487–1498

    PubMed  CAS  Google Scholar 

  2. Griggs RC, Askanas V, DiMauro S et al (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705–713

    Article  PubMed  CAS  Google Scholar 

  3. Badsrising UA, Maat-Schieman M, van Duinen SG et al (2000) Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 55:1385–1388

    Google Scholar 

  4. Liu LWC, Tarnoposlky M, Armstrong D (2004) Injection of botulism toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol 18(6):397–399

    PubMed  Google Scholar 

  5. Chahin N, Engel AG (2008) Correlation of muscle biopsy, clinical course, and outcome in PM and sIBM. Neurology 70(6):418–424

    Article  PubMed  Google Scholar 

  6. Engel WK, Askanas V (2006) Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 66:S20–S29

    Article  PubMed  Google Scholar 

  7. Derk CT, Vivino FB, Kenyon L, Mandel S (2003) Inclusion body myositis in connective tissue disorders: case report and review of the literature. Clin Rheumatol 22(4–5):324–328, Oct

    Article  PubMed  CAS  Google Scholar 

  8. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ (1989) Inclusion body myositis. Observations in 40 patients. Brain 112:727–747

    Article  PubMed  Google Scholar 

  9. Musial J, Undas A, Celinska-Lowenhoff M (2003) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Rheumatology (Oxford) 42(12):1566–1568, Dec

    Article  CAS  Google Scholar 

  10. Vershuuren JJ, Badrising UA, Wintzen AR et al (1997) Inclusion body myositis: An underdiagnosed myopathy in older people. In: Emery AEH (ed) Diagnostic Criteria for Neuromuscular Disorders. European Neuromuscular Centre. 2nd edn. The Royal Society of Medicine, London, pp 81–84

    Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen Tuck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalla, R., Soumakiyan, M. & Tuck, S. A case of inclusion body myositis responsive to prednisolone therapy. Clin Rheumatol 28 (Suppl 1), 21–22 (2009). https://doi.org/10.1007/s10067-008-1047-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1047-1

Keywords

Navigation